CSIMarket
 


Y mabs Therapeutics inc   (YMAB)
Other Ticker:  
 

Cumulative Y Mabs Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period

YMAB's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

YMAB Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth -31.87 % -17.71 % -10.75 % 1.47 % 26.25 %
Y / Y Cash & cash equivalent Growth -24.41 % -34.23 % -40.9 % -41.75 % -46.91 %
Quick Ratio for Trailing Twelve Months Period 3.72 3.63 3.86 4.3 4.95
Total Ranking # 631 # 704 # 738 # 794 # 738
Seq. Current Liabilities Growth -9.99 % -6.51 % -8.36 % -11.65 % 8.71 %
Seq. Cash & cash equivalent Growth -1.52 % -5.1 % -12.42 % -7.65 % -14.32 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Current Liabilities decreased faster than Y Mabs Therapeutics Inc 's average Cash & cash equivalent, this led to increase in in Y Mabs Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period to 3.72, Quick Ratio for Trailing Twelve Months Period remained below Y mabs Therapeutics inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 235 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Y Mabs Therapeutics Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about YMAB
Quick Ratio YMAB in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 236
Sector # 405
S&P 500 # 592


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
11.17 6.92 1.17
(Jun 30 2020)   (Sep 30 2019)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Kronos Bio Inc   10.11 
Shuttle Pharmaceuticals Holdings Inc   10.06 
Pepgen Inc   9.81 
Centessa Pharmaceuticals Plc  9.79 
Landos Biopharma Inc   9.76 
Compass Pathways Plc  9.74 
Cormedix Inc   9.72 
Allakos Inc   9.66 
Lumos Pharma Inc   9.56 
Protagonist Therapeutics inc   9.51 
Mineralys Therapeutics Inc   9.49 
Igm Biosciences Inc   9.47 
Annovis Bio inc   9.26 
Calcimedica Inc   9.24 
Ocuphire Pharma Inc   9.20 
Indaptus Therapeutics Inc   9.17 
Sol gel Technologies Ltd   9.12 
Histogen Inc   9.12 
Verrica Pharmaceuticals Inc   9.02 
Arcutis Biotherapeutics Inc   9.01 
Alx Oncology Holdings Inc  8.98 
Oncternal Therapeutics Inc   8.88 
Scpharmaceuticals Inc   8.80 
Immix Biopharma Inc   8.76 
Neurogene Inc   8.71 
Zentalis Pharmaceuticals Inc   8.71 
Aadi Bioscience Inc   8.68 
Phathom Pharmaceuticals Inc   8.61 
Dyne Therapeutics Inc   8.58 
Oragenics Inc   8.58 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com